Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
NCT02743468 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2026-05-22
Summary
Background:
Respiratory diseases affect more than 1 billion people worldwide. They are a growing public health concern. The lungs are constantly exposed to environmental factors such as dust, fumes, microbes, and pollutants. But much is still not known about how these pollutants lead to respiratory illnesses. Researchers want to collect samples from lungs and blood to see how genetics and environmental pollutants affect cellular responses or functioning.
Objectives:
To study how cytochrome P450 epoxygenase pathway enzymes affect macrophage function in the lungs and inflammatory responses.
Eligibility:
Adults ages 18 65 who can have a bronchoscopy.
Design:
All study visits will take place at the NIEHS Clinical Research Unit in Research Triangle Park, NC.
At study visit 1, participants will be screened with medical history and physical exam. They will have blood and urine tests. They will take tests that measure their lung function. They will answer questionnaires. Before the visit, they will be given a list of medicines they cannot take. They also must not have caffeine on the day of their visit. The visit will last about 3 hours.
At study visit 2, participants will give blood samples. They will undergo bronchoscopy. For this, they will get an intravenous line in a vein to get sedatives. Their airways will be numbed. Cells will be collected from their lungs. They will fast for 8 hours before the visit. They must have someone else drive them home from the visit. The visit will last about 3-4 hours.
Participants will get a follow-up phone call about 1 day after study visit 2.
Conditions
- Polymorphism
- Lung Inflammation
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Darryl C Zeldin, M.D. · National Institute of Environmental Health Sciences (NIEHS)
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-08
- Primary Completion
- 2019-12-18
- Completion
- 2023-09-21
Countries
- United States
Study Locations
More Related Trials
-
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
NCT00725309 ·Status: COMPLETED
-
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
NCT04722835 ·Status: UNKNOWN
-
Analysis of Anti-inflammatory and Antioxidant Pathways in Lung Diseases by Haem Oxygenase-1 (HO-1) in Induced Sputum and Carbon Monoxide (CO) in Exhaled Air
NCT01140685 ·Status: UNKNOWN
-
The Role of Airway Microbiota on Clinical Phenotypes and Disease Severity in Bronchiectasis
NCT05068518 ·Status: UNKNOWN
-
A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
NCT07245407 ·Status: RECRUITING
-
Optimization of Nutritional State on the Outcome of Patients with Acute Exacerbation of Bronchiectasis
NCT06704607 ·Status: NOT_YET_RECRUITING
-
Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis
NCT02976714 ·Status: COMPLETED ·Phase: NA
-
Respiratory Pathogens of Patients With Asthma and COPD Exacerbations
NCT02866357 ·Status: COMPLETED
-
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
NCT02168673 ·Status: COMPLETED
-
COPD Originates in Polluted Air
NCT02236039 ·Status: COMPLETED ·Phase: NA
-
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
NCT02187393 ·Status: WITHDRAWN
-
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
NCT00608764 ·Status: ACTIVE_NOT_RECRUITING
-
Blood Collection From Individuals With Lung Disease for Genetic Studies
NCT00362739 ·Status: COMPLETED
-
Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens
NCT02128711 ·Status: COMPLETED
-
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
NCT02487394 ·Status: TERMINATED
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
NCT02774226 ·Status: COMPLETED ·Phase: PHASE2
-
The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
NCT00974064 ·Status: COMPLETED
-
Optimization of Exhaled Biomarker Collection and Analysis
NCT05322785 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia
NCT03473119 ·Status: UNKNOWN
-
Air Pollution and Health of COPD Patients
NCT05076630 ·Status: COMPLETED
-
Sorting and Expression Profiling of Airway Cells From Humans (The SEARCH Study)
NCT02791542 ·Status: COMPLETED
-
Small Bioactive Molecules in Early COPD Diseases
NCT04950023 ·Status: UNKNOWN
-
Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK
NCT02468271 ·Status: COMPLETED
-
Evaluation of Reactive Oxygen Metabolites in the Value of COPD
NCT02297633 ·Status: UNKNOWN